Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL26645592

Fc1ccc(-c2nn3c(c2-c2ccncc2)CNCC3)cc1.O=C(O)C(F)(F)F

nearest known ligand 0.45

Full drug profile on Sugi Atlas →

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
MAPK14 Q16539 9/20 0.45
CSNK1D P48730 2/20 0.42
CSNK1E P49674 2/20 0.42
HTR3A P46098 1/20 0.41
SRC P12931 2/20 0.40
BRAF P15056 2/20 0.40
KDR P35968 2/20 0.40
MAPK11 Q15759 2/20 0.40
KCNH2 Q12809 1/20 0.40
EGFR P00533 1/20 0.38
RAF1 P04049 1/20 0.38
ADORA3 P0DMS8 1/20 0.38
ADORA2A P29274 1/20 0.38
ADORA2B P29275 1/20 0.38
ADORA1 P30542 1/20 0.38
GSK3B P49841 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24554415 0.90 MAPK14 (0.53) MAPK14CSNK1DCSNK1ESRCBRAF
Hydrochloric Acid SCHEMBL26645368 0.89 MAPK14 (0.52) MAPK14CSNK1DCSNK1ESRCBRAF
Trifluoroacetic Acid SCHEMBL26645121 0.88 PDE10A (0.36) MAPK14CSNK1DCSNK1EHTR3ASRC
Hydrochloric Acid SCHEMBL26645137 0.82 MAPK14 (0.45) MAPK14HTR3ASRCBRAFKDR
Hydrochloric Acid SCHEMBL26645132 0.82 MAPK14 (0.45) MAPK14SRCBRAFKDRMAPK11
SCHEMBL30623115 0.81 CSNK1E (0.43) MAPK14CSNK1DCSNK1EHTR3AMAPK11
Hydrochloric Acid SCHEMBL26645048 0.80 MAPK14 (0.43) MAPK14CSNK1DCSNK1ESRCBRAF
SCHEMBL25273468 0.79 GSK3B (0.45) MAPK14CSNK1DCSNK1EGSK3B
Hydrochloric Acid SCHEMBL26645169 0.79 PTGS2 (0.39) MAPK14HTR3ASRCBRAFKDR
Hydrochloric Acid SCHEMBL26645181 0.79 MAPK14 (0.37) MAPK14CSNK1DSRCBRAFKDR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023213882-A1 IRREVERSIBLE MUTEGFR INHIBITORS BAYER AKTIENGESELLSCHAFT (DE) 2023-11-09 WO disclosed